Retension Pharmaceuticals seeks Nasdaq listing
Retension Pharmaceuticals said it is seeking a Nasdaq Capital Market listing under a symbol.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.